SCHEMBL6132023

SCHEMBL6132023

Nc1n[nH]c(-c2ccccc2F)c1-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
RPS6KA3 P51812 1/20 0.56
AKT2 P31751 1/20 0.51
KMT2A Q03164 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPK14 Q16539 4/20 0.51
ILK Q13418 3/20 0.48
MAP4K4 O95819 1/20 0.45
CSF1R P07333 1/20 0.45
FGFR1 P11362 1/20 0.45
PDGFRA P16234 1/20 0.45
LTK P29376 1/20 0.45
KDR P35968 1/20 0.45
MAPK8 P45983 1/20 0.45
CSNK1A1 P48729 1/20 0.45
LIMK1 P53667 1/20 0.45
CDK5 Q00535 1/20 0.45
ACVR1 Q04771 1/20 0.45
TNK2 Q07912 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820038 0.81 MAPK1 (1.00) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132028 0.81 MAPK1 (0.67) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132032 0.81 MAPK1 (0.67) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132067 0.79 MAPK1 (0.80) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132080 0.79 MAPK1 (0.80) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132021 0.76 MAPK1 (0.70) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL19924485 0.74 MAP4K1 (0.47) MAPK1NPSR1AKT2KMT2AL3MBTL1
SCHEMBL6132051 0.73 MAPK1 (0.83) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL20722930 0.73 AKT2 (0.59) AKT2KMT2AILKKDM4EALDH1A1
SCHEMBL6132090 0.73 MAPK1 (0.70) MAPK1NPSR1RPS6KA3AKT2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP disclosed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP disclosed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed